ProfileGDS4718 / 228547_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 10% 8% 69% 2% 9% 1% 2% 2% 3% 6% 6% 1% 2% 2% 3% 17% 9% 2% 4% 1% 3% 8% 7% 4% 8% 3% 9% 7% 19% 4% 5% 7% 5% 7% 4% 2% 1% 3% 6% 67% 8% 2% 6% 2% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8064810
GSM549102patient 115, normal, homogenized [OPG study]3.703788
GSM549104patient 119, normal, homogenized [OPG study]6.8653369
GSM549108patient 138, normal, homogenized [OPG study]3.423752
GSM549119patient 077, normal, homogenized [OPG study]3.726559
GSM549133patient 032, cancer, homogenized [OPG study]3.329561
GSM549139patient 042, cancer, homogenized [OPG study]3.427472
GSM549099patient 107, normal, homogenized [OPG study]3.434192
GSM549109patient 139, normal, homogenized [OPG study]3.530023
GSM549110patient 046, normal, homogenized [OPG study]3.629176
GSM549114patient 063, normal, homogenized [OPG study]3.619716
GSM549122patient 082, normal, homogenized [OPG study]3.38621
GSM549134patient 033, cancer, homogenized [OPG study]3.436052
GSM549136patient 036, cancer, homogenized [OPG study]3.413072
GSM549140patient 044, cancer, homogenized [OPG study]3.462373
GSM549111patient 047, normal, homogenized [OPG study]3.999617
GSM549113patient 057, normal, homogenized [OPG study]3.705869
GSM549132patient 031, cancer, homogenized [OPG study]3.421712
GSM549137patient 038, cancer, homogenized [OPG study]3.540864
GSM549142patient 047, cancer, homogenized [OPG study]3.358011
GSM549100patient 110, normal, homogenized [OPG study]3.460713
GSM549107patient 135, normal, homogenized [OPG study]3.685458
GSM549115patient 068, normal, homogenized [OPG study]3.662247
GSM549116patient 072, normal, homogenized [OPG study]3.533364
GSM549120patient 078, normal, homogenized [OPG study]3.711648
GSM549131patient 030, cancer, homogenized [OPG study]3.44513
GSM549118patient 074, normal, homogenized [OPG study]3.742329
GSM549129patient 027, cancer, homogenized [OPG study]3.677197
GSM549123patient 088, normal, homogenized [OPG study]4.0987119
GSM549124patient 006, cancer, homogenized [OPG study]3.532854
GSM549126patient 015, cancer, homogenized [OPG study]3.56825
GSM549128patient 025, cancer, homogenized [OPG study]3.653767
GSM549103patient 117, normal, homogenized [OPG study]3.594295
GSM549117patient 073, normal, homogenized [OPG study]3.656157
GSM549138patient 041, cancer, homogenized [OPG study]3.502244
GSM549141patient 045, cancer, homogenized [OPG study]3.36842
GSM549130patient 028, cancer, homogenized [OPG study]3.345181
GSM549101patient 111, normal, homogenized [OPG study]3.465073
GSM549105patient 128, normal, homogenized [OPG study]3.613676
GSM549106patient 134, normal, homogenized [OPG study]6.6756567
GSM549112patient 048, normal, homogenized [OPG study]3.720458
GSM549125patient 011, cancer, homogenized [OPG study]3.436772
GSM549127patient 024, cancer, homogenized [OPG study]3.594296
GSM549135patient 035, cancer, homogenized [OPG study]3.420482